Qube Research & Technologies (QRT) Portfolio holdings
Qube Research & Technologies (QRT) is a British investment firm that trades with computer-driven models and began life inside Credit Suisse. It started in late 2016 as the Qube Fund, run by the bank's asset management unit for model-based strategies, and used computer models to trade stocks. Credit Suisse planned to spin the fund off because rules such as the Volcker Rule restricted banks from trading with their own money, and at the start of 2018 its management team bought the unit and renamed it Qube Research & Technologies. It runs a mix of strategies across many regions, asset classes and time horizons, with research teams of engineers, physicists, mathematicians, data scientists and fundamental analysts.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$1.31B |
| 2 |
NVIDIA
NVDA
|
+$1.03B |
| 3 |
Meta Platforms (Facebook)
META
|
+$840M |
| 4 |
Shopify
SHOP
|
+$815M |
| 5 |
Caterpillar
CAT
|
+$639M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1B |
| 2 |
Chevron
CVX
|
+$834M |
| 3 |
Sandisk
SNDK
|
+$632M |
| 4 |
Intercontinental Exchange
ICE
|
+$490M |
| 5 |
ExxonMobil
XOM
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.18% |
| 2 | Technology | 19.85% |
| 3 | Financials | 12.83% |
| 4 | Industrials | 10.55% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Chubb
CB
$144B
| $127M | 0.1% |
391,658
+260,690
| +199% | +$90M |
2022 Q1
18 quarters
|
|
227
Dollar General
DG
$29.6B
| $125M | 0.1% |
1,045,951
-253,634
| -20% | -$31.3M |
2023 Q1
14 quarters
|
|
228
Ford
F
$47.6B
| $125M | 0.1% |
10,351,592
+1,901,731
| +23% | +$26.4M |
2025 Q3
4 quarters
|
|
229
Ameren
AEE
$31.8B
| $124M | 0.1% |
1,250,454
+243,421
| +24% | +$26.3M |
2025 Q3
4 quarters
|
|
230
Centene
CNC
$35.3B
| $123M | 0.1% |
1,987,383
-59,801
| -3% | -$3.9M |
2026 Q1
2 quarters
|
|
231
Entergy
ETR
$53.1B
| $123M | 0.1% |
1,237,964
+1,091,677
| +746% | +$118M |
2026 Q2
1 quarter
|
|
232
Insulet
PODD
$10.6B
| $123M | 0.1% |
941,178
+277,210
| +42% | +$41.5M |
2025 Q2
5 quarters
|
|
233
CALL
Eli Lilly
LLY
$1.29T
| $123M | 0.1% |
106,000
+30,100
| +40% | +$35.5M |
2023 Q4
11 quarters
|
|
234
PUT
Alphabet (Google) Class C
GOOG
$3.6T
| $122M | 0.1% |
358,500
-13,500
| -4% | -$4.65M |
2024 Q4
7 quarters
|
|
235
American International
AIG
$43B
| $122M | 0.1% |
1,637,280
-1,205,900
| -42% | -$93.2M |
2026 Q1
2 quarters
|
|
236
PUT
Salesforce
CRM
$179B
| $122M | 0.1% |
530,000
-229,300
| -30% | -$47.3M |
2023 Q3
12 quarters
|
|
237
Clean Harbors
CLH
$15.5B
| $122M | 0.1% |
391,999
+144,921
| +59% | +$45.2M |
2026 Q2
1 quarter
|
|
238
Pentair
PNR
$10.9B
| $121M | 0.1% |
+2,284,476
| New | +$145M |
2026 Q3
0 quarters
|
|
239
Pinterest
PINS
$11B
| $119M | 0.1% |
+6,290,053
| New | +$138M |
2026 Q3
0 quarters
|
|
240
Unum
UNM
$12.4B
| $119M | 0.1% |
1,351,857
-536,092
| -28% | -$48.6M |
2025 Q4
3 quarters
|
|
241
Expeditors International
EXPD
$25.2B
| $119M | 0.1% |
642,067
+55,875
| +10% | +$10.2M |
2021 Q4
19 quarters
|
|
242
DELISTED
Kenvue
KVUE
| $119M | 0.1% |
6,710,514
+3,664,721
| +120% | +$69M |
2026 Q1
2 quarters
|
|
243
Emcor
EME
$28.9B
| $118M | 0.1% |
156,724
-171,285
| -52% | -$132M |
2023 Q2
13 quarters
|
|
244
Teva Pharmaceutical Industries Limited
TEVA
$51.9B
| $118M | 0.1% |
+2,976,366
| New | +$106M |
2026 Q3
0 quarters
|
|
245
CALL
Marvell Technology
MRVL
$141B
| $117M | 0.1% |
444,300
+19,500
| +5% | +$4.37M |
2023 Q3
12 quarters
|
|
246
PUT
JPMorgan Chase
JPM
$919B
| $117M | 0.1% |
354,000
+171,000
| +93% | +$59.8M |
2023 Q2
13 quarters
|
|
247
UDR
UDR
$11.5B
| $116M | 0.09% |
3,457,027
+2,648,215
| +327% | +$99.3M |
2026 Q2
1 quarter
|
|
248
Diamondback Energy
FANG
$51.6B
| $116M | 0.09% |
630,341
+552,639
| +711% | +$108M |
2026 Q2
1 quarter
|
|
249
CALL
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
| $116M | 0.09% |
+1,131,900
| New | +$120M |
2026 Q3
0 quarters
|
|
250
Edwards Lifesciences
EW
$61.6B
| $115M | 0.09% |
1,331,753
+917,315
| +221% | +$81.5M |
2025 Q2
5 quarters
|
|
Similar funds
Qube Research & Technologies (QRT)'s Q3 2026 Portfolio in Review
As of Q3 2026, Qube Research & Technologies (QRT) held 4,268 positions worth $123B, up 14% from $108B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $13.6B of net new capital in Q3 2026, opening 862 new positions and adding to 1,394 existing holdings. Its largest new stake was Caterpillar: 753,166 shares worth $611M.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1B trimmed.
- Qube Research & Technologies (QRT)'s largest Q3 2026 buy was Caterpillar: 753,166 shares worth $611M.
- Qube Research & Technologies (QRT) added most to Warner Bros in Q3 2026, an estimated $1.31B increase.
- Qube Research & Technologies (QRT)'s biggest Q3 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1B.
- Qube Research & Technologies (QRT) fully exited Intercontinental Exchange in Q3 2026, selling an estimated $490M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $123B portfolio in Q3 2026.
- Qube Research & Technologies (QRT) opened 862 new positions and closed 641 in Q3 2026.
- Qube Research & Technologies (QRT)'s portfolio value rose 14% quarter-over-quarter to $123B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.